Implantable Telescopes Gets Federal Approval
Patients with end-stage, age-related macular degeneration and thus are hoping to improve their vision will welcome a decision made by the Food and Drug Administration (FDA).
The federal body approved the use of Implantable Miniature Telescope (IMT), which are micro-sized and designed to replace the natural lens.
“This innovation has the potential to provide many people with an improved quality of life,” said Jeffrey Shuren, MD, JD, the director of the FDA’s Center for Devices and Radiological Health.
IMT was developed by VisionCare Ophthalmic Technologies Inc. of Saratoga, California.
Macular degeneration is a medical condition, which usually affects older adults that results in a loss of vision in the center of the visual field (the macula) because of damage to the retina.
Around 8 million suffer from it while nearly 2 million of them already lost significant vision.
The IMT, despite being as small as a pea, is large enough to create problems to the cornea of the eye. It can lead to extensive loss of cells needed to maintain cornea clarity.